Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Monteris Medical NeuroBlate System

K-Number: K171255 · 2017-07-25

Decision Date2017-07-25
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Monteris Medical NeuroBlate System is a medical device manufactured by Monteris Medical, Inc.. It received FDA 510(k) clearance on 2017-07-25 under approval number K171255. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Monteris Medical NeuroBlate System?

Monteris Medical NeuroBlate System is a medical device that received FDA 510(k) clearance on 2017-07-25. It is manufactured by Monteris Medical, Inc.. The 510(k) number is K171255.

When was Monteris Medical NeuroBlate System approved by the FDA?

Monteris Medical NeuroBlate System received FDA 510(k) clearance on 2017-07-25, under approval number K171255.

What company makes Monteris Medical NeuroBlate System?

Monteris Medical NeuroBlate System is manufactured by Monteris Medical, Inc..

What is the FDA product code for Monteris Medical NeuroBlate System?

The FDA product code for Monteris Medical NeuroBlate System is GEX. This falls under the Gastroenterology category.

Related Clinical Trials

Related PubMed Literature

Other Devices by Monteris Medical, Inc.

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.